france was reported by one study as 32% in males and 42% in females. in germany, the prevalence was reported at 32% in people aged between 35 and 44 years, and 20% in those aged 65–74. in jordan, another study reported a lifetime prevalence of 26%. research main article: herpes simplex research research has gone into vaccines and drugs for both prevention and treatment of herpes infections.